Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase

Biochemical and Biophysical Research Communications

Volumn 337, Issue 1, 2005, Pages 104-109

  Vandevoorde, Séverine ^a   Saha, Bijali ^b   Mahadevan, Anu ^b   Razdan, Raj K ^b   Pertwee, Roger G ^c   Martin, Billy R ^d   Fowler, Christopher J ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b ORGANIX INC   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

2 Arachidonoylglycerol; Anandamide; Fatty acid amide hydrolase; Monoacylglycerol lipase

Indexed keywords

1 ARACHIDONOYLGLYCEROL; 1 MONOMYRISTIN; 1 MONOPALMITIN; ACYL CARRIER PROTEIN; ACYLGLYCEROL LIPASE; FATTY ACID AMIDASE; GLYCEROL DERIVATIVE; TRIPALMITIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CHEMICAL BOND; CHEMICAL STRUCTURE; DRUG POTENCY; HYDROLYSIS; IC 50; ISOMERISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

AMIDOHYDROLASES; ARACHIDONIC ACIDS; ENZYME INHIBITORS; FATTY ACIDS, UNSATURATED; GLYCERIDES; MONOACYLGLYCEROL LIPASES;

EID: 25844465639     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.015     Document Type: Article

References (38)

1. V. Di Marzo, and I. Matias Endocannabinoid control of food intake and energy balance Nat. Neurosci. 8 2005 585 589
2. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol. Biochem. Behav. 81 2005 331 342
3. B.F. Cravatt, and A.H. Lichtman The endogenous cannabinoid system and its role in nociceptive behavior J. Neurobiol. 61 2004 149 160
4. M.A. Diana, and A. Marty Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE) Br. J. Pharmacol. 142 2004 9 19
5. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
6. R. Mechoulam, S. Ben Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, D.R. Compton, R.G. Pertwee, G. Griffin, M. Bayewitch, J. Barg, and Z. Vogel Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1995 83 90
7. T. Sugiura, S. Kondo, A. Sugukawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, and K. Waku 2-Arachidonylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun. 215 1995 89 97
8. D.G. Deutsch, and S.A. Chin Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist Biochem. Pharmacol. 46 1993 791 796
9. S.K. Goparaju, N. Ueda, H. Yamaguchi, and S. Yamamoto Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand FEBS Lett. 422 1998 69 73
10. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, S.L. Sensi, S. Kathuria, and D. Piomelli Brain monoglyceride lipase participating in endocannabinoid inactivation Proc. Natl. Acad. Sci. USA 99 2002 10819 10824
11. S.M. Saario, J.R. Savinainen, J.T. Laitinen, T. Järvinen, and R. Niemi Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes Biochem. Pharmacol. 67 2004 1381 1387
12. T.P. Dinh, S. Kathuria, and D. Piomelli RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol Mol. Pharmacol. 66 2004 1260 1264
13. J.K. Makara, M. Mor, D. Fegley, S.I. Szabó, S. Kathuria, G. Astarita, A. Duranti, A. Tontini, G. Tarzia, S. Rivara, T.F. Freund, and D. Piomelli Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus Nature Neurosci. 8 2005 1139 1141
14. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
15. A.I. Gulyas, B.F. Cravatt, M.H. Bracey, T.P. Dinh, D. Piomelli, F. Boscia, and T.F. Freund Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala Eur. J. Neurosci. 20 2004 441 458
16. P.C. Schmid, M.L. Zuzarte-Augustin, and H.H.O. Schmid Properties of rat liver N-acylethanolamine amidohydrolase J. Biol. Chem. 260 1985 14145 14149
17. W. Lang, C. Qin, S. Lin, A.D. Khanolkar, A. Goutopoulos, P. Fan, K. Abouzid, Z. Meng, D. Biegel, and A. Makriyannis Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase J. Med. Chem. 42 1999 896 902
18. D.L. Boger, R.A. Fecik, J.E. Patterson, H. Miyauchi, M.P. Patricelli, and B.F. Cravatt Fatty acid amide hydrolase substrate specificity Bioorg. Med. Chem. Lett. 10 2000 2613 2616
19. H. Tornqvist, and P. Belfrage Purification and some properties of a monoacylglycerol-hydrolysing enzyme of rat adipose tissue J. Biol. Chem. 251 1976 813 819
20. Y. Ikeda, K. Okamura, and S. Fujii Purification and characterisation of rat liver microsomal monoacylglycerol lipase in comparison to the other esterases Biochim. Biophys. Acta 488 1977 128 139
21. M. Hee-Cheong, and D.L. Severson Properties of monoacylglycerol lipase in rabbit aorta Lipids 22 1987 999 1004
22. N. Ghafouri, G. Tiger, R.K. Razdan, A. Mahadevan, R.G. Pertwee, B.R. Martin, and C.J. Fowler Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol Br. J. Pharmacol. 143 2004 774 784
23. C.A. Rouzer, K. Ghebreselasie, and L.J. Marnett Chemical stability of 2-arachidonoyl-glycerol under biological conditions Chem. Phys. Lipids 119 2002 69 82
24. E.W. Ng, M.M. Aung, M.E. Abood, B.R. Martin, and R.K. Razdan Unique analogues of anandamide: arachidonoyl ethers and carbamates and norarachidonoyl carbamates and ureas J. Med. Chem. 42 1999 1975 1981
25. L. Han, and R.K. Razdan Total synthesis of 2-arachidonylglycerol (2-Ara-Gl) Tetrahedron Lett. 40 1999 1631 1634
26. O. Dasse, A. Mahadevan, L. Han, B.R. Martin, V. Di Marzo, and R.K. Razdan The synthesis of N-vanillyl-arachidonoyl-amide (arvanil) and its analogs: an improved procedure for the synthesis of the key synthon methyl 14-hydroxy-(all-cis)-5,8,11,-tetradecatrienonate Tetrahedron 56 2000 9195 9202
27. C.R. Harrington Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determination on fractions from brain tissue Anal. Biochem. 186 1990 285 287
28. S. Vandevoorde, and C.J. Fowler Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11 (N-(4-hydroxy-2-methylphenyl) arachidonoylamide): evidence that VDM11 acts as an FAAH substrate Br. J. Pharmacol. 145 2005 885 893
29. S. Kathuria, S. Gaetani, D. Fegley, F. Valiño, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. La Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, and D. Piomelli Modulation of anxiety through blockade of anandamide hydrolysis Nature Med. 9 2003 76 81
30. C.J. Fowler, and G. Tiger Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro Biochem. Pharmacol. 69 2005 1241 1245
31. I. Matias, J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, F. Fezza, A.H.-P. Krauss, L. Shi, C.E. Protzman, C. Li, Y. Liang, A.L. Nieves, K.M. Kedzie, R.M. Burk, V. Di Marzo, and D.F. Woodward Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism J. Pharmacol. Exp. Ther. 309 2004 745 757
32. A.H. Lichtman, D. Leung, S.C. Shelton, A. Saghatelian, C. Hardouin, D.L. Boger, and B.F. Cravatt Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity J. Pharmacol. Exp. Ther. 311 2004 441 448
33. C. Hillard, D. Wilkison, W. Edgemond, and W. Campbell Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain Biochim. Biophys. Acta 1257 1995 249 256
34. T. Bisogno, D. Melck, L. De Petrocellis, M.Y. Bobrov, N.M. Gretskaya, V.V. Bezuglov, N. Sitachitta, W.H. Gerwick, and V. Di Marzo Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase Biochem. Biophys. Res. Commun. 248 1998 515 522
35. D.R. Compton, and B.R. Martin The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity J. Pharmacol. Exp. Ther. 283 1997 1138 1143
36. M. Bifulco, C. Lawezza, M. Valenti, A. Ligresti, G. Portella, and V. Di Marzo A new strategy to block tumor growth by inhibiting endocannabinoid inactivation FASEB J. 18 2004 1606 1608
37. V. Di Marzo, T. Bisogno, T. Sugiura, D. Melck, and L. De Petrocellis The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide Biochem. J. 331 1998 15 19
38. D. Panikashvili, C. Simeonidou, S. Ben-Shabat, L. Hanus, A. Breuer, R. Mechoulam, and E. Shohami An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 2001 527 531